Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3597_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
87 Мб
Скачать
262 5
https://t.me/med1917
IN) over the guidewire and position in the suprarenal abdominal aorta. Advance a 5- to 6-F IMA catheter, multipurpose, or JR4 through the long sheath and engage the renal artery (Figs. 5-10 through 5-12).
Peripheral Arterial Disease and Angiography
Assessment of Renal Artery Stenosis Significance
Standard selective angiography provides a limited 2D view of the renal artery. Because many clinical trials, predicated on the identification of RAS using angiographic measurement, have yielded discordant data on the clinical benefit of renal artery revascularization, there has been great interest in developing reliable strategies to predict those patients who will most likely benefit from renal artery revasculariza­tion. In patients with RAS due to FMD, it has been well validated that PTA alone is sufficient to disrupt the webs of tissue responsible for causing the stenosis and is often highly effective to reduce associated HTN (Fig. 5-13). However, in patients with atherosclerotic disease, debate persists regarding who serves most to benefit from revascular­ization. Similar to the practice in CAD, there has been a recent move­ment to define significant RAS, not by anatomic severity, but rather by physiologic impact using pressure wire evaluation with induction of hyperemia. Of note, adenosine should not be used in the renal vascu­lature for the induction of vasodilation because it can paradoxically provoke renal artery vasoconstriction. The optimal vasodilator for the renal vasculature is papaverine, which must be used with heparin-free saline, because the combination of these two drugs leads to formation of a precipitate that may provoke microvascular injury. Some studies have evaluated the use of other vasodilators, including dopamine. A hemodynamically significant RAS is characterized by one of the fol­lowing conditions: (1) resting pressure distal to stenosis/pressure in the aorta (Pd/Pa) <0.90, (2) hyperemic Pd/Pa called fractional flow reserve (FFR) for the coronary circulation <0.80, (3) hyperemic mean gradient > (5) minimal luminal area (MLA) by intravascular ultrasound (IVUS) imaging of 8.6 mm2 or less. Given the limitations of angiography, any intermediate stenosis should likely be assessed using one of these techniques.
20 mm Hg, (4) hyperemic systolic gradient >20 mm Hg, and
Renal Artery Revascularization
Indications for renal artery revascularization include facilitation of BP control in patients with resistant HTN, preservation of renal function, or reversal of end-stage renal failure or prevention of a decline in renal function in selected patients. Renal artery stenting has also been shown to improve functional class in patients with unstable angina and CHF.
Large-scale randomized clinical trials (including DRASTIC, ASTRAL, and STAR), testing the efficacy of renal artery revasculariza­tion versus medical management, have concluded that renal artery stenting does not confer significant benefit compared with medical therapy. Significant methodologic flaws have limited translation of these results to general clinical practice. The most recent CORAL trial enrolled patients with relatively mild clinical indications (patients took two antihypertensive medications), and physiologic assessment of lesion severity was not required. Considering these limitations, renal artery revascularization produced modest improvement in BP control during these clinical trials. Further prospective randomized studies with physiologic determination of stenosis severity may provide greater insight in determining those patients who may benefit from renal artery revascularization.
https://t.me/med1917
5
Peripheral Arterial Disease and Angiography 263
Figure 5-10 Aortogram showing bilateral renal ar tery stenosis (R AS)
(arrows).
Figure 5-11 Right renal artery stenosis (R AS).
264 5
https://t.me/med1917
Peripheral Arterial Disease and Angiography
Figure 5-12 Angiogram of right renal artery after stenting.
Figure 5-13 Angiogram demonstrating fibromuscular dysplasia (FMD) of
the renal arter y. (Image courtesy of Dr. Michael Jaf f.)
Subclavian and Brachiocephalic Intervention
Upper-extremity arterial insufficiency due to obstructive disease of the major aortic arch vessels affects up to 7% of individuals in select popu­lations. Atherosclerotic disease most commonly involves the ostium
https://t.me/med1917
or proximal segments of the subclavian and brachiocephalic arteries; in other conditions, such as FMD, large vessel vasculitides (e.g., Takayasu arteritis, giant cell arteritis), thoracic outlet syndrome, or radiation-induced disease may cause lesions in more distal locations.
Symptoms of subclavian obstruction include arm claudication with fatigue, paresthesia, or pain during exertion. The presence of stenosis may first be identified by discrepant BP readings between arms, with a lower BP recorded on the affected side. Proximal left subclavian stenosis may also impede antegrade flow through the left vertebral artery, resulting in symptoms of vertebrobasilar insufficiency that may manifest as diplopia or vertigo with left arm exertion, known as subclavian steal. In patients with left or right internal mammary (LIMA or RIMA) bypass grafting for coronary artery bypass graft (CABG) surgery, the presence of proximal subclavian stenosis may result in angina during arm exercise or periods of physiologic subcla­vian steal.
5
Peripheral Arterial Disease and Angiography 265
Noninvasive Testing
In patients with suspected obstructive disease of the upper extremi­ties, CTA or MRA may be helpful to confirm the diagnosis and provide anatomic insight. Imaging studies permit assessment of arch anatomy and degree of atherosclerotic burden and may be helpful for proce­dural planning if revascularization is considered. Duplex ultrasound may be used to evaluate vertebral artery flow on the affected side. Reversal of vertebral flow found on Duplex characterizes subclavian steal physiology. Presence of the steal phenomenon alone does not warrant revascularization unless the disease involves the left subcla­vian artery and the LIMA is intended for use in CABG surgery. To confirm the diagnosis of subclavian steal syndrome (vs. phenomenon alone), patients must have symptoms of vertebral-basilar insufficiency (VBI), angina, or arm claudication.
Invasive DSA may provide enhanced anatomic detail. Arch aor­tography using a pigtail catheter placed into the ascending aorta at 40 degrees LAO defines the origins of the great vessels and permit selec­tive angiography if needed. The determination of translesional pres­sure gradients to determine the significance of intermediate lesions involving the arch vessels may be diagnostic of important stenosis. Selective canalization of the vessels may be performed using a variety of specialized catheters; in cases where prolonged catheter manipula­tion is required, anticoagulation is recommended.
Revascularization
Revascularization of the brachiocephalic and subclavian arteries is indicated for the presence of significant symptoms or empirically if a LIMA is required as a conduit for CABG surgery. Endovascular treat­ment of the subclavian and brachiocephalic arteries is successful in more than 95% of cases. Surgical bypass is possible but has a com­paratively high rate of complications, including cranial nerve palsy, lymphocoele, and morbidity related to the need to enter into the chest cavity. To date, there have been no trials comparing outcomes with open surgical revascularization and endovascular therapy in subcla­vian and innominate artery distribution.
The optimal approach to upper-extremity revascularization depends on lesion location and arch anatomy. The femoral approach is most often used, although brachial or radial access may facilitate treatment of CTOs, where it may be difficult to localize the vessel’s origin from the aortic arch or maintain adequate catheter support to cross the occlusion. Radial access is gaining popularity and most
266 5
https://t.me/med1917
balloon-expandable stent platforms up to 8 mm may be delivered through 6-F sheath systems and postdilatated up to 10 mm with 6-F compatible balloons. Simultaneous femoral and arm access may permit embolic protection of the vertebral artery or carotid in the case of innominate intervention or in cases where complex proximal plaque is felt to pose a particularly high risk for DE.
balloon-expandable stents, because radial force is desirable, precision of deployment is imperative, and this territory is not exposed to extrin­sic compression. For lesions located in the more distal portions of these vessels, self-expanding stents may be preferred to accommodate extremity movement and the propensity for flexion, extrinsic compres­sion, and other forces that could result in stent deformation.
ing complication that occurs due to the direct route to cerebral circula­tion through the vertebral artery. Some operators advocate for the use of cerebral embolic protection at the time of treatment for bulky sub­clavian or brachiocephalic lesions. No large studies have evaluated the safety or efficacy of this approach, but given the unknown timing of vertebral flow reversal, some operators recommend embolic pro ­tection. In the rare event of acute thrombotic occlusions of the arch vessels, embolic protection to vertebral and axillary arteries seems prudent, because more DE may occur at the time of instrumentation.
Peripheral Arterial Disease and Angiography
Aorto-ostial and proximal lesions are generally treated with
Atheroembolization, although uncommon, represents a devastat-
Carotid Disease
In the United States, cerebrovascular disease remains the third leading cause of death and represents a significant cause of morbidity and health care expenditure. Approximately 800,000 individuals develop a new or recurrent stroke each year, of which two-thirds are first-time events and one-third are recurrent. Although 80% of strokes are isch­emic in origin and result from long-standing HTN, 20% to 25% are due to atherosclerotic disease of the carotid artery. The risk of stroke from carotid artery plaque itself depends on both the severity of narrowing as well as characteristics of the plaque biology—that is, whether a prior stroke or transient ischemic attack (TIA) has occurred from an unstable lesion.
The highest risk of recurrent stroke occurs in the context of symp­tomatic severe carotid lesions of 70% to 99% as established by angiog­raphy. These data, described in the North American Symptomatic Carotid Endarterectomy Trial (NASCET), firmly established that the risk of recurrent ipsilateral stroke at a 2-year follow-up was 26%. In less severe but symptomatic stenosis (50% to 69%), the 5-year risk of any ipsilateral stroke was 22.2%. The highest risk of stroke occurred early after the index event, highlighting the importance of early revascular­ization. Although medical therapy at the time of NASCET was limited, the benefit of early revascularization of symptomatic patients with carotid disease is now well established.
Asymptomatic patients enrolled in the Asymptomatic Carotid Surgery Trial (ACST) with a carotid stenosis more than 60% (deter­mined by ultrasound) were found to have a stroke risk of 11% at 5-year follow-up. In contrast to symptomatic patients, who have a high risk of recurrent stroke early after an index event, the risk of stroke in asymptomatic patients was constant during the 5-year period, imply­ing that revascularization in these patients may be considered on a more elective basis.
Diagnostic Testing
Duplex ultrasonography is the standard test used to assess coronary artery stenosis (CAS). Numerous criteria have been established to
https://t.me/med1917
assist in the diagnosis severe carotid stenosis. In most cases, greater than 80% stenosis correlates with PSV of 300 to 400 cm/sec, an EDV greater than 100 cm/sec, and a ratio of internal carotid artery/common carotid artery (ICA/CCA) systolic velocity of more than 4. Other fea­tures, such as the presence of contralateral occlusion, diminished cardiac output from severe left ventricular (LV) dysfunction, valvular pathology such as aortic stenosis, and concomitant CCA stenosis, may render these measurements less reliable. MRA and CTA may also facilitate the identification of CAS. Still, catheter-based angiography remains the gold standard for evaluating carotid stenosis. Angiography provides information on vessel anatomy, plaque morphology, flow characteristics, and presence of collateral circulation. These param­eters are particularly useful in predicting the safety of carotid endar­terectomy (CEA) or carotid artery stenting. However, angiography also carries risks of vascular complications and plaque embolization, although these events are uncommon.
5
Peripheral Arterial Disease and Angiography 267
Carotid and Cerebral Angiography
Carotid and cerebral angiography is most commonly performed from the femoral artery approach. However, in some cases, right radial or brachial arterial access may be preferred. Regardless of approach, meticulous procedural technique must be used during carotid and cerebral angiography. It is recommended that anticoagulation with heparin be achieved to prevent catheter- and/or wire-related thrombo­sis and embolism. Careful flushing and back-bleeding of every cath­eter must be performed to prevent air or thromboembolism. In most cases, selective angiography of the great vessels should not be completed without first performing a nonselective angiogram of the aortic arch.
Standard baseline arch aortography is using a pigtail catheter with power injection (typical volume of 40 cc) in a LAO 30- to 40-degree orientation. There should be limited foreshortening of the catheter. This position permits visualization of the origins and proximal seg­ments of the great vessels and enables determination of arch type, which may indicate any potential technical challenges related to per­forming selective carotid angiography.
The aortic arch typically gives rise to the brachiocephalic trunk, the left CCA, and the left subclavian artery. The brachiocephalic trunk usually bifurcates into the right subclavian artery and right CCA. In 20% to 30% of the population, the brachiocephalic trunk and left CCA share a common origin. The aortic arch can be classified into three types, defined by Myla and described by Uflacker et al., on the basis of the distance of the origin of the great vessels from the top of the arch (Fig. 5-14). The widest diameter of the left common carotid is used as a reference vessel. In a type-I arch, all great vessels originate within one diameter length (diameter length of the widest portion of the left common carotid) from the top of the arch; in a type-II arch, all great vessels originate within two diameter lengths from the top of the arch; and in a type-III arch, the great vessels originate within more than two diameter lengths from the top of the arch (see Fig. 5-9). In addition, a small segment of the population has the left carotid artery originating from the innominate artery. This is known as a “bovine arch” (Fig. 5-15). Given the potential variability in arch configuration and the marked impact that anomalous configurations have on proce­dural technique, arch aortography is a critical first step.
Various-shaped catheters are available for selective carotid and vertebral artery angiography. The catheters can be divided into three groups: passive, intermediate, and active shape designs. Use of a particular category of catheter will depend on the type of aortic arch and the geometry of the origins of the great vessels. Passive catheters, such as headhunter, multipurpose, vertebral, and Beren­stein, are used to access the great vessels in patients with a type-I
268 5
https://t.me/med1917
Peripheral Arterial Disease and Angiography
Type-I
aortic arch
Figure 5-14 Schematic diagram showing classification of aortic arch.
Figure 5-15 Bovine arch angiogram demonstrating the left common
carotid arising from the innominate arter y (arrow).
Type-II
aortic arch
Type-III
aortic arch
aortic arch. Intermediate catheters, including the Vitek (Cook, Inc, Medical, Bloomington, IN) and Bentson (JB 1–3; Cordis Corp., Hialeah, FL), require more manipulation than passive catheters and are ideal for type-II aortic arches. Active catheters including the Simmons Side­winder and Newton catheter are useful for type-II or -III arches but must be shaped in the ascending aorta and therefore may introduce the opportunity for release of atheroemboli. A practical way to shape these catheters requires advancing them into the aortic arch over a wire (an angled Glidewire is recommended). With removal of the wire, the catheter may then be retracted and the tip positioned in the left subclavian artery. Further rotation will allow the catheter to prolapse into the ascending aorta. The catheter can then be manipulated into each specific great vessel.
Following the review of arch aortography, selection of an appro­priate catheter, and assurance that systemic anticoagulation has been achieved, the great vessels may then be engaged. The right anterior oblique (RAO) view allows visualization of the origins of the right common carotid, right subclavian, and right and left vertebral arteries (Figs. 5-16 and 5-17). The LAO view allows visualization of the left common carotid and left subclavian and innominate arteries. Follow­ing selective engagement of the common carotid from the arch (or innominate), wiring of the common carotid is often required to allow the catheter to be advanced and appear in the field of view for quan­titative angiography of carotid bifurcation. Take care with any wire or catheter advancement to prevent the catheter from jumping forward into the lesion. Angiography performed from the proximal or middle portion of the common carotid (if not diseased) is usually sufficient.
https://t.me/med1917
5
Peripheral Arterial Disease and Angiography 269
Figure 5-16
Once the diagnostic catheter is in place, angiography of the carotid bifurcation in the AP, lateral, and ipsilateral oblique (45 degrees) is obtained. The carotid artery is classically divided into four segments: cervical, petrous (often washed out in appearance as the artery courses through the petrous bone), cavernous, and supraclinoid.
With the catheter selectively in each carotid artery, obtain intra­cranial imaging in both the AP cranial and lateral projections. Although additional discussion is beyond the scope of this chapter, any operator performing selective carotid and intracranial angiography should be familiar with the anatomy of the major cerebral vessels and branches and should recognize congenital variations as well as the presence or absence of collateral vessels when intracranial disease is present.
Ulcerated plaque in internal carotid artery (ICA).
Vertebral Disease
In contrast to carotid disease, the optimal management of vertebral artery stenosis is less well known, in large part because the manifesta­tions of vertebral disease may be ambiguous and underappreciated. Vertebral arteries provide the blood supply to the posterior aspect of the brain, including the cerebellum. Ischemic insults to this area may manifest with dizziness, ataxia, diplopia, hemiparesis, and bilateral lower-extremity weakness and numbness. The vertebral arteries merge together to form the basilar artery; occlusion of the basilar artery presents as “locked in” syndrome, in which the patient may only control lateral movement of the eyes.
270 5
https://t.me/med1917
Peripheral Arterial Disease and Angiography
Figure 5-17 Poststent angiogram of internal carotid artery (ICA).
The primary cause of posterior circulation strokes is embolization from the heart, aorta, or proximal aspect of the vertebral arteries themselves. Transient ischemia of the posterior circulation may also occur in the context of “inflow” vessel (subclavian or innominate artery) stenosis or occlusion, where flow is further compromised by transient reduction in BP, or during episodes where “steal” physiology reduces antegrade flow, classically with strenuous use of the ipsilat­eral arm.
Atherosclerosis represents the most common cause of vertebral artery stenosis, primarily concentrated at the vessel origin. Other, less common causes of vertebral artery stenosis include arterial dissection (usually traumatic), FMD, migraine, and vasculitides, such as Takayasu and giant cell arteritis. The diagnosis of VBI is often quite challenging due to vague and indistinct symptoms.
The location of the arteries and their intercervical course make duplex ultrasonography challenging. The best tests for assessing ver­tebral arteries include CTA, MRA, and invasive angiography.
Vertebral arteries most commonly arise from the proximal portion of the subclavian artery, although in 5% of patents, the left vertebral may arise directly from the arch. Classically, the vertebral artery is divided into four segments, designated V1 to V4. The V1 section is the one most affected by atherosclerosis and extends from the origin to the point at which the vessel enters the transverse foramina of the vertebra (C5 to C6) where it then becomes the V2 section. From the intervertebral foramina, the vertebral courses behind C2 extracranialy
https://t.me/med1917
5
Peripheral Arterial Disease and Angiography 271
(the V3 section) and then enters the skull through the foremen magnum, where it is then called the V4 segment. This final portion enters into the brain and merges with the contralateral vertebral artery to form the basilar artery. It is common to find a size discrepancy between the two vertebral arteries, with the left often the larger of the two. The larger vertebral is often referred to as the “dominant” vessel.
Conclusion
Peripheral arterial disease is prevalent and encompasses a wide spec­trum of disorders. Clinicians must be vigilant for vascular disease, since the diagnosis confers high risk of adverse cardiovascular events. Once diagnosed, the mainstay of treatment for PAD is medical therapy, focused on the modification of cardiovascular risk factors. Exercise therapy may substantially improve symptoms of claudication, but for the select patients who fail conservative therapy, there are a growing number of endovascular and surgical therapeutic options. Through keen understanding of clinical and anatomic features, as well as appreciation of the range of therapeutic strategies, we may tailor our approach to optimize outcomes for our patients.
Suggested Readings
Adam DJ, Beard JD, Cleveland T, et al: Bypas s versus angioplasty in severe ischaemia of
the leg (BASIL): multicentre, randomised controlled trial. Lancet 366:1925–1934, 2005.
Barnett HJ, Taylor DW, Eliasziw M, et al: Benefit of carotid endarterectomy in patients
with symptomatic moderate or severe stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med 339:1415–1425, 1998.
Bates ER, Babb JD, Casey DE, Jr, et al: ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical expert
consensus document on carotid stenting: a report of the American College of Cardiol­ogy Foundation Task Force on Clinical E xpert Consensus Documents (ACCF/SCAI/ SVMB/SIR /ASITN Clinical E xpert Consensus Document Committee on Carotid Stent­ing). J Am Coll Cardiol 49:126–170, 2007.
Bonaca MP, Scirica BM, Creager MA, et al: Vorapaxar in patient s with peripheral arter y
disea se: result s from TRA2°P-TIMI 50. Circulation 127(14):1522–1529, 1529e1–e6, 2013.
Brott TG, Halperin JL, Abbara S, et al: 2011 ASA/ACCF/AHA /AANN/AANS/ACR/ASNR/
CNS/SAIP/SCA I/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summar y: a repor t of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, Amer ican Association of Neurological Surgeons, American College of Radiolog y, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Societ y for Cardiovas­cular Angiography and Interventions, Society of Interventional Radiolog y, Society of NeuroInter ventional Surgery, Society for Vascular Medicine, and Society for Vascular Surger y. Developed in collaboration with the American Academy of Neurolog y and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 57:1002–1044,
2011.
Brott TG, Hobson RW 2nd, Howard G, et al: Stenting versus endarterectomy for treatment
of carotid artery stenosis. N Engl J Med 363:11–23, 2010.
Cooper CJ, Murphy TP, Cutlip DE, et al: Stenting and medical therapy for atherosclerotic
renal-arter y stenosis. N Engl J Med 370(1):13–22, 2014.
Criqui MH, Langer RD, Fronek A, et al: Mortalit y over a period of 10 years in patients with
peripher al arterial disease. N Engl J Med 326:381–386, 1992.
Dake MD, Ansel GM, Jaff MR, et al: Sustained safet y and effectiveness of paclitaxel- eluting
stents for femoropopliteal lesions: two-year follow-up from the Zilver PTX r andom­ized and single-arm clinical studies. J Am Coll Cardiol 61:2417–2427, 2013.
Dawson DL, Cutler BS, Meissner MH, et al: Cilosta zol ha s beneficial effects in treatment
of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 98:678–686, 1998.
Diener HC, Bogousslavsky J, Brass LM, et al: Aspirin and clopidogrel compared with
clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high­risk patients (MATCH): randomised, doubleblind, placebo-controlled trial. Lancet 364:331–337, 2004.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterec-
tomy for asymptomatic carotid arter y stenosis. JAMA 273:1421–1428, 1995.
Geraghty PJ, Mew issen MW, Jaff MR, et al: Three-year results of the VIBRANT trial of
VIABA HN endoprosthesis versus bare nitinol stent implantation for complex super ­ficial femoral artery occlusive disease. J Vasc Surg 58:386 –395, 2013.
Hirsch AT, Haskal ZJ, Hertzer NR, et al: ACC/AHA 2005 Practice Guidelines for the
management of patient s with peripheral arterial disease (lower extremity, renal, mesenter ic, and abdominal aortic): a collaborative repor t from the